Research programme: herpes simplex virus vaccine - PaxVax/University of California at San DiegoAlternative Names: Genital herpes vaccine - PaxVax/UCSD; Herpes simplex combination vaccine
Latest Information Update: 13 Jun 2014
At a glance
- Originator PaxVax; University of California, San Diego
- Class Viral vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Research Herpes simplex virus infections
Most Recent Events
- 10 Jun 2014 Early research in Herpes simplex virus infections in USA (Parenteral)